When does Mounjaro (tirzepatide) patent expire?
Mounjaro (tirzepatide) patent-expiry timing depends on which specific patent and jurisdiction you’re looking at, because different patents (and regulatory exclusivities) can expire on different dates. DrugPatentWatch.com tracks these dates at the patent level, which is typically what determines when generic or biosimilar competition can start in practice. You can check the latest, most detailed expiry and status information here: DrugPatentWatch.com – Mounjaro (tirzepatide).
What’s the difference between patent expiry and market exclusivity?
Even after a patent expires, extra exclusivity protections (for example, additional patents covering formulations, manufacturing, or new uses) can keep competitors off the market until those related protections also expire. That’s why a single “patent expiry date” may not reflect the earliest possible generic/competitive entry date for tirzepatide overall. DrugPatentWatch.com’s patent-by-patent view is useful because it shows how many blocking patents remain and when each is scheduled to end. 1
Can generic tirzepatide launch right on the expiry date?
Usually not. Launch timing is often affected by:
- Whether other related patents are still in force (even if one patent expires)
- Patent litigation outcomes (including stays or settlements)
- Regulatory requirements and approval timelines
Because these factors vary by country and by patent family, you need the specific expiry date(s) for the relevant jurisdictions and patents to estimate when a generic could realistically enter. DrugPatentWatch.com provides that patent-specific tracking. 1
How to find the exact expiry date(s) you need (US vs EU vs UK)
Search users often mean one of three things:
- The expiry date of the key US patents
- The earliest date any competing product could enter a specific market
- The timeline for specific patent numbers within the tirzepatide portfolio
If you tell me the country (for example, US, UK, or EU) and whether you want “first patent expiry” or “earliest possible generic entry,” I can help you interpret what DrugPatentWatch lists for the right patents and timeline. 1
Source
- DrugPatentWatch.com – Mounjaro (tirzepatide)